If you need support without making an already tough process more complicated, download MeAgain and turn your GLP-1 journey into a fun game
Who May Be at Greater Risk of Mood Changes People with a history of depression, eating disorders, or poorly controlled type 2 diabetes may be more vulnerable to mood changes and warrant closer monitoring during retatrutide treatment
Here we show that, at least for cAMP generation, GLP-1 936 amide is a low potency, weak partial agonist of the GLP-1R in a system with high receptor expression (HEK-GLP-1R cells) but provides little or no agonism in a system with lower receptor expression (INS-1E cells)
Cardiovascular Protection : Clinical evidence suggests it helps reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established heart disease
Barrington JW, Lindsay P, James D, Smith S, Roberts A